Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Clinical trial NCT06333769 · COMPLETED

Trial details

NCT number: NCT06333769
Sponsor: Fujian Cancer Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mid-low Rectal Cancer

Start date: 2024-07-12
Primary completion: 2025-08-10
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.